Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody

Monoclonal antibody therapy for Junin virus infection

(2016) Larry Zeitlin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

(2016) D. Corti et al.   SCIENCE

Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak

(2016) Z. A. Bornholdt et al.   SCIENCE

Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus

(2015) Andrew I. Flyak et al.   CELL

Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus

(2015) Scott A. Smith et al.   Cell Host & Microbe

A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs

(2015) Chad E. Mire et al.   JOURNAL OF INFECTIOUS DISEASES

Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model

(2015) Robert W. Cross et al.   JOURNAL OF INFECTIOUS DISEASES

Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection: Table 1.

(2015) Thomas W. Geisbert et al.   JOURNAL OF INFECTIOUS DISEASES

The therapeutic monoclonal antibody market

(2014) Dawn M Ecker et al.   mAbs

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

(2014) Xiangguo Qiu et al.   NATURE

Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy

(2014) A. Hiatt et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA

(2014) E. P. Thi et al.   Science Translational Medicine

Therapeutic Treatment of Nipah Virus Infection in Nonhuman Primates with a Neutralizing Human Monoclonal Antibody

(2014) T. W. Geisbert et al.   Science Translational Medicine

Protective Antiviral Antibodies that Lack Neutralizing Activity: Precedents and Evolution of Concepts

(2013) Alan Schmaljohn   CURRENT HIV RESEARCH

Human Monoclonal Antibodies Derived From Memory B Cells Following Live Attenuated Dengue Virus Vaccination or Natural Infection Exhibit Similar Characteristics

(2013) Scott A. Smith et al.   JOURNAL OF INFECTIOUS DISEASES

Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA

(2013) Raul Ursic-Bedoya et al.   JOURNAL OF INFECTIOUS DISEASES

Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model

(2013) Larry Zeitlin et al.   mAbs

Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail

(2013) J. Pettitt et al.   Science Translational Medicine

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease

(2012) J. M. Dye et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

(2012) G. G. Olinger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant

(2011) L. Zeitlin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Neutralizing Human Monoclonal Antibody Protects African Green Monkeys from Hendra Virus Challenge

(2011) K. N. Bossart et al.   Science Translational Medicine

Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches

(2009) James E. Crowe   VACCINE